Literature DB >> 15265156

Outcomes after renal transplantation for FSGS in children.

Michelle A Baum1.   

Abstract

Focal segmental glomerulosclerosis (FSGS) is the primary diagnosis resulting in end-stage renal disease in approximately 12% of children receiving renal transplantation. Recurrent FSGS after transplantation is unpredictable and clear risk factors have not been identified. Post-transplantation, the incidence of acute tubular necrosis requiring dialysis is higher in children with FSGS compared with other diagnoses and may represent immediate severe recurrence. Graft survival is decreased in children with FSGS compared with other primary diagnoses, and the impact is greatest in recipients of living donor transplants. Graft loss caused by recurrent FSGS is significantly higher in living donor transplants compared with cadaveric donor transplants in children. Compared with adults, the impact of FSGS on graft survival appears to be greatest in children. White recipient race is associated with a higher risk of graft loss from recurrent FSGS. Efforts to elucidate the mechanisms of recurrent FSGS and to understand risk factors based on genetics, potential circulating cytokines and permeability factors, age and race must move forward before we can significantly impact outcomes in renal transplantation for FSGS. Copyright 2004 Blackwell Munksgaard

Entities:  

Mesh:

Year:  2004        PMID: 15265156     DOI: 10.1111/j.1399-3046.2004.00181.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  18 in total

1.  Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.

Authors:  Alessia Fornoni; Junichiro Sageshima; Changli Wei; Sandra Merscher-Gomez; Robier Aguillon-Prada; Alexandra N Jauregui; Jing Li; Adela Mattiazzi; Gaetano Ciancio; Linda Chen; Gaston Zilleruelo; Carolyn Abitbol; Jayanthi Chandar; Wacheree Seeherunvong; Camillo Ricordi; Masami Ikehata; Maria Pia Rastaldi; Jochen Reiser; George W Burke
Journal:  Sci Transl Med       Date:  2011-06-01       Impact factor: 17.956

Review 2.  Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013.

Authors:  Caitlin E Carter; Nadine M Benador
Journal:  Pediatr Nephrol       Date:  2013-06-29       Impact factor: 3.714

3.  Urine proteomic profiling of pediatric nephrotic syndrome.

Authors:  Mona Khurana; Avram Z Traum; Manuel Aivado; Meghan P Wells; Manuel Guerrero; Franck Grall; Towia A Libermann; Asher D Schachter
Journal:  Pediatr Nephrol       Date:  2006-06-30       Impact factor: 3.714

4.  Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis.

Authors:  Juhi Kumar; Ibrahim F Shatat; Amy L Skversky; Robert P Woroniecki; Marcela Del Rio; Eduardo M Perelstein; Valerie L Johnson; Shefali Mahesh
Journal:  Pediatr Nephrol       Date:  2012-10-04       Impact factor: 3.714

5.  Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.

Authors:  Changli Wei; Shafic El Hindi; Jing Li; Alessia Fornoni; Nelson Goes; Junichiro Sageshima; Dony Maiguel; S Ananth Karumanchi; Hui-Kim Yap; Moin Saleem; Qingyin Zhang; Boris Nikolic; Abanti Chaudhuri; Pirouz Daftarian; Eduardo Salido; Armando Torres; Moro Salifu; Minnie M Sarwal; Franz Schaefer; Christian Morath; Vedat Schwenger; Martin Zeier; Vineet Gupta; David Roth; Maria Pia Rastaldi; George Burke; Phillip Ruiz; Jochen Reiser
Journal:  Nat Med       Date:  2011-07-31       Impact factor: 53.440

6.  Long-term outcome of focal segmental glomerulosclerosis after pediatric renal transplantation.

Authors:  Gabriel M Cara Fuentes; Carmen Garcia Meseguer; Antonia Peña Carrion; Marta Melgosa Hijosa; Araceli Garcia-Pose; Angel Alonso Melgar; Mercedes Navarro Torres
Journal:  Pediatr Nephrol       Date:  2009-12-03       Impact factor: 3.714

7.  Treatment of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: effect of rituximab.

Authors:  Christine Sethna; Corinne Benchimol; Hilary Hotchkiss; Rachel Frank; Lulette Infante; Suzanne Vento; Howard Trachtman
Journal:  J Transplant       Date:  2011-04-26

Review 8.  Podocyte pathology and nephropathy - sphingolipids in glomerular diseases.

Authors:  Sandra Merscher; Alessia Fornoni
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-30       Impact factor: 5.555

Review 9.  Long-term outcome after renal transplantation in childhood.

Authors:  Lesley Rees
Journal:  Pediatr Nephrol       Date:  2007-08-09       Impact factor: 3.714

Review 10.  Pediatric renal transplantation.

Authors:  B Saeed
Journal:  Int J Organ Transplant Med       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.